US Subcommittee Examines Toxic Substances Control Act, IP Protection 11/07/2013 by Intellectual Property Watch Leave a Comment A subcommittee of the United States House of Representatives Energy and Commerce Committee today heard arguments for and against greater chemical regulation and trade secret protection in its review of the Toxic Substances Control Act (TSCA). The hearing also examined the Environmental Protection Agency (EPA)’s role in regulation.
WHO Priority Medicines Report Sees Drop In R&D Productivity 11/07/2013 by Intellectual Property Watch 1 Comment Decline in pharmaceutical research and development productivity is one of the main challenges addressed in the 2013 edition of the World Health Organization report, Priority Medicines for Europe and the World. Whether the decline in pharmaceutical R&D is due to R&D depletion, overly strict regulatory hurdles, or the current pharmaceutical business model remains unanswered.
“Trilateral” Symposium Addresses Topics Of Global Public Health And IP 10/07/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment The themes of innovation, collaboration, and policy coherence shared the spotlight during panel discussions at the 5 July technical symposium on Medical Innovation: Changing Business Models. The event was jointly hosted by the World Health Organization, World Intellectual Property Organization, and World Trade Organization.
WHO, WTO, WIPO Heads Call For More Medical Innovation 08/07/2013 by Brittany Ngo for Intellectual Property Watch 3 Comments The leaders of three top international organisations in Geneva last week discussed synergies in public health and called for increased collaboration and creativity to move medical innovation out of its quagmire of inefficiency. The opening session was marked by the head of the World Health Organization urging stakeholders to develop mechanisms to separate drug prices from costs of research and development. And the head of the GAVI Alliance, in the keynote address, discussed how patent thickets could impede access to vaccines.
ECOSOC Panel: Science, Technology, Innovation Essential For Universal Health Coverage 04/07/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment A United Nations Economic and Social Council (ECOSOC) panel discussion on universal health coverage (UHC) on 3 July highlighted the importance of science, technology and innovation for achieving UHC, especially in the context of the post-2015 development agenda. Speakers discussed the meaning and scope of UHC as well as the financing and promotion of UHC in various country contexts.
Special Feature: A Look At Product Development Partnerships And Innovation For Neglected Diseases 03/07/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch Leave a Comment An analysis of available information indicates that research-oriented product development partnerships (PDPs) are seen as providing a better approach to neglected diseases than most other public-private partnerships. Yet, in spite of many positive results, PDPs still have a limited impact in developing countries.
MSF: Prices On Latest ARV Drugs Under Patent Too High 02/07/2013 by Intellectual Property Watch Leave a Comment The price of first- and second-line anti-retrovirals (ARVs) have declined due to increased generic competition, while third-line regimens remain “exorbitantly priced,” according to the latest edition of a publication from Médecins Sans Frontières (MSF).
WHO Issues Guidelines To Push HIV Epidemic Into “Irreversible Decline” 30/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment The World Health Organization (WHO) has issued new recommendations that call for earlier HIV treatment with antiretroviral therapy (ART) in an effort to keep HIV patients healthier for a longer period of time.
Medicines Patent Pool Signs New Licence Agreements 26/06/2013 by Intellectual Property Watch 1 Comment The Medicines Patent Pool, Shilpa Medicare, and Gilead Sciences have signed an agreement to increase access to HIV treatment medicines. The agreement will allow Shilpa Medicare to manufacture “five key HIV medicines for sale in 100-112 countries,” and the goal is to cover “a majority of people living with HIV.”
UNAIDS Reports Sharp Drop In New HIV Infections In Some African Countries 26/06/2013 by Intellectual Property Watch Leave a Comment Since 2009, seven countries in sub-Saharan Africa have reduced new HIV infections among children by 50 percent, and others have made significant progress, according to a new report by UNAIDS. But efforts in some countries have stalled, it said.